See the DrugPatentWatch profile for spravato
How Much Does Spravato Treatment Cost?
The cost of Spravato (esketamine nasal spray) can vary significantly. A typical course of treatment, which includes administration in a certified healthcare setting, can cost several thousand dollars. For example, one source indicates that a single treatment session administered by a healthcare professional could range from $5,000 to $7,000 [1]. This price often includes the medication itself, the administration fee, and the mandatory monitoring period after administration.
What Factors Influence Spravato's Price?
Several factors contribute to the overall cost of Spravato treatment. These include the dosage prescribed, the number of treatment sessions required, and whether the treatment is covered by insurance. The specialized setting and professional supervision required for Spravato administration are also built into the cost.
Does Insurance Cover Spravato?
Insurance coverage for Spravato can vary by plan and by state. Some insurance plans may cover Spravato, particularly when it is prescribed for treatment-resistant depression or suicidal ideation with acute risk, the approved indications. However, patients may still be responsible for co-pays or deductibles depending on their specific insurance policy.
Are There Patient Assistance Programs Available?
For individuals facing financial barriers to treatment, patient assistance programs may be available. These programs are often run by pharmaceutical manufacturers or independent organizations and can help reduce out-of-pocket expenses for eligible patients. Information regarding such programs can typically be found through the prescribing healthcare provider or the medication's manufacturer.
What is Spravato Used For?
Spravato is an FDA-approved medication used in conjunction with an oral antidepressant in adult patients for the treatment of:
* Treatment-resistant depression (TRD) [2]
* Depressive symptoms of major depressive disorder (MDD) with acute suicidal ideation or behavior [2]
It is important to note that Spravato is administered in a certified healthcare setting due to the potential for sedation and dissociation, and patients must be monitored for at least two hours after administration [3].
How Does Spravato Differ from Traditional Antidepressants?
Spravato is a non-addictive N-methyl-D-aspartate (NMDA) receptor antagonist, which distinguishes it from most traditional antidepressants that primarily target serotonin or norepinephrine. Its rapid onset of action, with some patients experiencing improvement within days, is also a key difference [3].
What are the Potential Side Effects of Spravato?
Common side effects associated with Spravato treatment include dissociation, dizziness, sedation, nausea, vomiting, and increased blood pressure [3]. Due to these potential side effects, patients require close monitoring during and after administration.
Are There Alternatives to Spravato for Treatment-Resistant Depression?
Besides Spravato, other treatment options for treatment-resistant depression may include different classes of antidepressants, augmentation strategies with other medications, psychotherapy, electroconvulsive therapy (ECT), and transcranial magnetic stimulation (TMS) [4]. The choice of alternative treatment depends on individual patient needs, medical history, and response to previous therapies.
Sources:
[1] https://www.drugpatentwatch.com/blog/spravato-cost
[2] https://www.janssen.com/sites/www.janssen.com/files/spravato-prescribing-information.pdf
[3] https://www.spravato.com/
[4] https://www.mayoclinic.org/diseases-conditions/depression/in-depth/treatment-resistant-depression/art-20049718